Edesa Biotech, Inc. Made Big Gain

Edesa Biotech, Inc. (EDSA:NASDAQ) rocketted at $8.15, representing a gain of 40.3%. The stock got featured on our News Catalysts scanner on Fri 21 Aug 20 at 04:26 PM in the 'BIOTECH' category. From Thu 13 Aug 20, the stock recorded 30.00% Up Days and 45.45% Green Days

The stock spiked on Thu 30 Jul 20 at $19.1 with a volume of 45M+, and its share price has been moving sideways in recent weeks.

About Edesa Biotech, Inc. (EDSA:NASDAQ)

Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.